Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06535503 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Site details revised at 2 of 2 sitesv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A retrospective study on the clinical characteristics and treatment outcomes of patients admitted with ST-elevation Myocardial Infarction (STEMI) complicated with cardiogenic shock (CS) during admission or CS development during their hospital stay for two tertiary hospitals in Abu Dhabi, UAE, from 2020-2024.
Trial Details
NCT Number NCT06535503
Lead Sponsor Abu Dhabi Health Services Company
Collaborators: Sheikh Shakhbout Medical City, Sheikh Khalifa Medical City
Conditions
(from sponsor)		 ST Elevation Myocardial Infarction, Cardiogenic Shock
Related terms Shock, Cardiogenic, ST Elevation Myocardial Infarction
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov